The global surgical hemostats, internal tissue sealants and adhesion barriers market is set to cross US$ 5 Billion by 2024, expanding at a CAGR of over 8% during the next eight years. North America will continue to lead the market, accounting for almost 47% share of the global market over the assessment period.

1. Global Market Study on Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers:
MEA Regional Market Anticipated to Witness 1.6X
Growth over the Forecast Period

2. North America Wound Debridement Products Market by 2024
PersistenceMarketResearch
Report Media Releases
Global Surgical Hemostats, Internal Tissue Sealants and
Adhesion Barriers Market is Estimated to cross US$ 5,717 Mn
by 2024
The global surgical hemostats, internal tissue sealants and adhesion barriers
market is set to cross US$ 5 Billion by 2024, expanding at a CAGR of over 8% during the next
eight years. North America will continue to lead the market, accounting for almost 47% share of
the global market over the assessment period.
Persistence Market Research (PMR) indicates that the global market will witness a steady
growth owing to factors such as challenges before adhesive prevention, changing nature of
clinical needs and higher caseload across the globe. In addition, key players operating in the
global market are actively focusing on strategic collaborations in order to extend their product
reach across narrower distribution channels. This, in turn, is anticipated to support the growth of
market over the next couple of years. However, this steep increase in overall surgical procedures
will not necessarily cover-up for the complications associated with adhesion and internal tissue
sealants surgeries, as advanced minimally invasive surgical procedures have higher efficiency
with reduced size and severity of surgical wounds.
As per PMR’s report, the existence of handful established brands that are running globally and
uneven structure of the market is expected to present lucrative market opportunities for local
players over the forecast period.
A Sample of this Report is Available Upon Request @
http://www.persistencemarketresearch.com/samples/3417
On the basis of product type, the hemostats product segment is estimated to reach a market
valuation of US$ 2.2 Billion by the closing end of the assessment period. In terms of value, the
segment is estimated to increase 1.9x over 2024 despite recording a relatively low CAGR.
Whereas, demand for synthetic polymer based internal tissue sealants is expected to gain
traction in the near future. This is primarily due to increased product offerings for tissue sealants
by manufacturers leading to market exclusivity. Moreover, increasing focus on developing
advanced surgical sealants and adhesion barriers owing to the inadequacy of hemostatic
products such as oxidized regenerated cellulose based and gelatin based hemostats that are
eventually reaching limitation. Demand for adhesion barriers surgeries is also poised to grow at a
handsome pace, reflecting a CAGR of 9.2% between 2016 and 2024.
Based on end user, hospitals is anticipated to be the leading segment, expanding at over 9%
CAGR over the assessment period. The segment will be benefited by the increasing availability
of low cost procedures associated with the use of hemostats in various cases.
Based on regional prospects, North America will retain the major share of the global market over
2024 followed by Europe. In addition, the market in North America is expected to create an
incremental opportunity of closely to US$ 1,642 Million during 2016 to 2026. Europe being the
second largest market is set to rake in US$ 1.2 Billion in revenues over 2024, with the UK,
Germany and France occupying the top three spots of the market in the region. A sharp rise in

3. North America Wound Debridement Products Market by 2024
PersistenceMarketResearch
the number of cardiovascular surgeries in countries such as China, Australia and Japan is
expected to present lucrative market opportunities in the Asia Pacific region during the projected
period. Moreover, rapid launch of new products and service extension of existing products in
both APAC and Europe is a major factor expected to drive the growth prospects of the market in
these regions.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/market-
research/surgical-hemostat-internal-tissue-sealant-adhesion-barrier-market/toc
Key player operating in the global market for surgical hemostats, internal tissue sealants and
adhesion barriers market include Baxter international Inc., Tissuemed Ltd., C.R. Bard Inc. (Davol
Inc.), B. Braun Melsungen AG (Asculap), Ethicon Inc. (Johnson & Johnson), Cryolife Inc.,
Cohera Medical, Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Sanofi, and CSL
Behring (CSL Ltd.). Most of these companies are actively focusing on completing strategic
mergers and acquisitions to achieve higher product penetration.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-
research/surgical-hemostat-internal-tissue-sealant-adhesion-barrier-market.asp
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Our offerings include pre-built reports that address every major sale, customized solutions to
cater to client-specific needs, and consulting services to offer more value addition. Our next-
generation research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.

4. North America Wound Debridement Products Market by 2024
PersistenceMarketResearch
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
transforming data from multiple streams into a strategic asset.
Contact Us:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com/
media@persistencemarketresearch.com
Stay updated with our official Blog: http://pmrblog.com